ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

"The CRISPR technology was introduced as an mRNA," Coller said. "That is the critical feature ... The cuts are sending ...

"Report Uncovers Key Trends, Disease Insights and Clinical Trials Shaping the Future of the Global mRNA Therapeutics Market"Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

Curevac N.V. (($CVAC)) announced an update on their ongoing clinical study. Study Overview: CureVac N.V. is conducting a Phase I study titled ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Hanmi Pharmaceutical, the core business subsidiary of Hanmi Science, unveiled a range of next-generation modality research achievements at a ...

By: DANNY QUAH Can adversarial nations work together for the common good? It’s natural to despair over prospects for international cooperation given the state of the world order. Geopolitical ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

GEO-CM04S1 Designed to Deliver Broader, More Durable Protection for the 40 Million Americans Left Vulnerable by Limited Effectiveness of Current Vaccines ATLANTA, GA - October 28, 2025 (NEWMEDIAWIRE) ...

Melbourne researchers have developed a new RNA drug designed to prevent the damaging effects of the debilitating autoimmune disease lupus, in a major ...

Cambridge, UK, 27 October 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products announces that, following Investigational New Drug (IND) approval from the FDA, a ...